25454795|t|Impacts of aging and amyloid-beta deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
25454795|a|Plasminogen activators (PAs), which convert plasminogen into the fibrinolytic protease plasmin, may initiate the degradation of amyloid-beta (Abeta) to suppress the amyloid pathogenesis. In that way, tissue plasminogen activator (tPA)-mediated plasmin activation could maintain a low level of Abeta deposition to delay the pathogenesis of Alzheimer's disease (AD). In a previous study, we reported that tPA/plasmin proteolytic activity is attenuated throughout the brain during aging or with Abeta accumulation but clustered intense around the amyloid plaques in AD brain. The present study demonstrates that the altered proteolytic activity primarily results from the competition between the expressions of tPA and plasminogen activator inhibitor-1 (PAI-1) in the brains of Tg2576 Abeta-transgenic mice, as revealed by immunohistochemistry and immunoblot assays. Compared with that in the brains of younger Tg2576 mice, tPA protein is generally reduced throughout the brain in older Tg2576 mice but elevated near amyloid plaques. In contrary, PAI-1 expression increases during aging or Abeta deposition with its clusters surrounding amyloid plaques. No significant alteration in the expression of urokinase plasminogen activator (uPA) is detected. These results suggest reciprocal feedback influences between tPA, PAI-1 and Abeta during aging and amyloid pathogenesis in AD brain; tPA-mediated plasmin activity is declined throughout the brain causing Abeta deposition during aging, and the Abeta deposits locally attract the cluster of tPA and/or PAI-1 around their deposits to competitively determine tPA/plasmin-mediated Abeta proteolysis.
25454795	21	33	amyloid-beta	Disease	MESH:C000718787
25454795	75	108	plasminogen activator inhibitor-1	Gene	18787
25454795	116	122	Tg2576	CellLine	CVCL:S723
25454795	123	128	mouse	Species	10090
25454795	138	157	Alzheimer's disease	Disease	MESH:D000544
25454795	203	214	plasminogen	Gene	18815
25454795	301	306	Abeta	Gene	11820
25454795	324	331	amyloid	Disease	MESH:C000718787
25454795	359	387	tissue plasminogen activator	Gene	18791
25454795	389	392	tPA	Gene	18791
25454795	452	457	Abeta	Gene	11820
25454795	498	517	Alzheimer's disease	Disease	MESH:D000544
25454795	519	521	AD	Disease	MESH:D000544
25454795	562	565	tPA	Gene	18791
25454795	651	656	Abeta	Gene	11820
25454795	703	718	amyloid plaques	Disease	MESH:D058225
25454795	722	724	AD	Disease	MESH:D000544
25454795	867	870	tPA	Gene	18791
25454795	875	908	plasminogen activator inhibitor-1	Gene	18787
25454795	910	915	PAI-1	Gene	18787
25454795	934	940	Tg2576	CellLine	CVCL:S723
25454795	941	946	Abeta	Gene	11820
25454795	958	962	mice	Species	10090
25454795	1067	1073	Tg2576	CellLine	CVCL:S723
25454795	1074	1078	mice	Species	10090
25454795	1080	1083	tPA	Gene	18791
25454795	1143	1149	Tg2576	CellLine	CVCL:S723
25454795	1150	1154	mice	Species	10090
25454795	1173	1188	amyloid plaques	Disease	MESH:D058225
25454795	1203	1208	PAI-1	Gene	18787
25454795	1246	1251	Abeta	Gene	11820
25454795	1293	1308	amyloid plaques	Disease	MESH:D058225
25454795	1357	1388	urokinase plasminogen activator	Gene	18792
25454795	1390	1393	uPA	Gene	18792
25454795	1469	1472	tPA	Gene	18791
25454795	1474	1479	PAI-1	Gene	18787
25454795	1484	1489	Abeta	Gene	11820
25454795	1507	1514	amyloid	Disease	MESH:C000718787
25454795	1531	1533	AD	Disease	MESH:D000544
25454795	1541	1544	tPA	Gene	18791
25454795	1612	1617	Abeta	Gene	11820
25454795	1651	1656	Abeta	Gene	11820
25454795	1697	1700	tPA	Gene	18791
25454795	1708	1713	PAI-1	Gene	18787
25454795	1763	1766	tPA	Gene	18791
25454795	1784	1789	Abeta	Gene	11820
25454795	Association	11820	18791
25454795	Association	MESH:D058225	18787
25454795	Association	MESH:D000544	18791
25454795	Association	MESH:C000718787	18787
25454795	Association	MESH:D000544	18787
25454795	Association	MESH:D000544	11820
25454795	Bind	18787	18791
25454795	Association	MESH:C000718787	11820
25454795	Positive_Correlation	11820	18787

